XML 45 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation (Narrative) (Details)
6 Months Ended
Jun. 30, 2020
USD ($)
item
$ / shares
shares
Jun. 30, 2019
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of stock-based compensation plans | item 4  
Unrecognized compensation cost related to unvested awards under share-based plans | $ $ 15,600,000  
Cost expected to be recognized over a weighted average period 2 years 4 months 24 days  
Share-based Payment Arrangement, Expense | $ $ 3,000,000.0 $ 3,000,000.0
Restricted Stock Units (RSUs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Granted (in shares) | shares 1,531,702 930,831
Granted (in dollars per share) | $ / shares $ 6.87  
Options Granted (in dollars per share) | $ / shares   $ 8.57
Restricted Stock Units (RSUs) [Member] | Share-based Payment Arrangement, Tranche One [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Vesting period 3 years 3 years
Granted (in shares) | shares 1,387,602 863,331
Restricted Stock Units (RSUs) [Member] | Share-based Payment Arrangement, Tranche Two [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Vesting period 1 year 1 year
Granted (in shares) | shares 144,100 67,500
Stock Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Options Granted (in shares) | shares 300,000 65,104
Vesting period 4 years  
Stock option exercised (in shares) | shares 74,000 0
Total intrinsic value of options exercised | $ $ 310,280  
Options Granted (in dollars per share) | $ / shares $ 3.02 $ 3.84
Options exercised and vested in period, total intrinsic value | $ $ 6,200,000 $ 4,000,000.0
Restricted Stock Units And Stock Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | $ $ 5,000,000.0 $ 3,500,000